Assessing Clinical Response and Defining Minimal Disease Activity in Plaque Psoriasis with the Physician Global Assessment and Body Surface Area (PGA X BSA) Composite Tool: An Analysis of Apremilast Phase 3 ESTEEM Data

Authors

Alice B. Gottlieb, New York Medical CollegeFollow
Joseph Merola
R Chen
E Levi
K Duffin

DOI

10.1016/j.jaad.2017.06.162

Journal Title

Journal of the American Academy of Dermatology

First Page

1178

Last Page

1180

Document Type

Letter to the Editor

Publication Date

12-1-2017

Department

Dermatology

Keywords

Body Surface Area, Psoriasis drug therapy, Thaliomide therapeutic use

Disciplines

Dermatology | Medicine and Health Sciences | Skin and Connective Tissue Diseases

Recommended Citation

Gottlieb, A. B., Merola, J., Chen, R., Levi, E., & Duffin, K. (2017). Assessing Clinical Response and Defining Minimal Disease Activity in Plaque Psoriasis with the Physician Global Assessment and Body Surface Area (PGA X BSA) Composite Tool: An Analysis of Apremilast Phase 3 ESTEEM Data. Journal of the American Academy of Dermatology, 77 (6), 1178-1180. https://doi.org/10.1016/j.jaad.2017.06.162